DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR OXYCODONE HYDROCHLORIDE
Clinical Trials for Oxycodone Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT00000273 | A Laboratory Model for Heroin Abuse Medications - 8 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration." |
| NCT00000273 | A Laboratory Model for Heroin Abuse Medications - 8 | Completed | New York State Psychiatric Institute | Phase 2 | The purpose of this study is to evaluate the effects of treatment medications (methadone, buprenorphine, LAAM, naltrexone, naltrexone microcapsules, and methoclocinnamox) on I.V. and smoked heroin self-administration." |
| NCT00027014 | Herb-Opioid Interactions | Completed | National Center for Complementary and Integrative Health (NCCIH) | Phase 4 | This is a series of studies in healthy volunteers to assess the potential for adverse interactions between St. John's wort (SJW) extract and two narcotic (opioid) pain medications: oxycodone and fentanyl. In the case of oxycodone, we are interested in whether SJW treatment promotes the metabolism of oxycodone, such that it lowers the effectiveness of standard doses of oxycodone in treating pain problems. For the fentanyl study, we will investigate whether SJW treatment will interfere with the delivery of fentanyl to the brain and diminish it's effectiveness to relieve pain. There is evidence to suggest that SJW treatment may increase the activity of a transporter protein, named P-glycoprotein (Pgp), in the blood-brain barrier (BBB) that protects the brain from exposure to drugs and other dietary and environmental toxins. |
| NCT00092313 | A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery. |
| NCT00092326 | A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183) | Completed | Merck Sharp & Dohme Corp. | Phase 3 | The purpose of this study is to compare the safety and effectiveness of two approved drugs in the treatment of pain following dental surgery. |
| Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Oxycodone Hydrochloride
Condition Name
Condition MeSH
Clinical Trial Locations for Oxycodone Hydrochloride
Trials by Country
Clinical Trial Progress for Oxycodone Hydrochloride
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Oxycodone Hydrochloride
Sponsor Name
